Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB057643 in advanced malignancies
NCT02711137Phase 2Terminated
- Sponsor
- Incyte
- Start
- May 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of INCB-057643 in solid tumor, lymphoma, acute leukemia, myelodysplastic syndrome (MDS), Myeloproliferative Neoplasm (MPN), sponsored by Incyte. Started May 2016; status: terminated.
02
Drugs
INCB-057643
03
Conditions
solid tumorlymphomaacute leukemiamyelodysplastic syndrome (MDS)Myeloproliferative Neoplasm (MPN)
Beyond the preview
Go deeper on NCT02711137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02711137.